{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:26:41Z","timestamp":1757615201211,"version":"3.44.0"},"reference-count":37,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"unspecified","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Abertawe Bro Morgannwg University Health Board","award":["Pathway to Portfolio"],"award-info":[{"award-number":["Pathway to Portfolio"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,8,18]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Gestational diabetes mellitus (GDM) is common in pregnancy and is increasing in prevalence. It is associated with an increased risk of maternal and perinatal complications if not diagnosed and managed early. Most guidelines suggest making a diagnosis of GDM using an oral glucose tolerance test (OGTT) between 24 and 28 weeks of pregnancy at which stage there still is an increased risk of complications. Increased beta-cell secretory product concentrations have been observed prior to changes in glycaemia and can potentially be used as an early marker to diagnose and assess risk of developing GDM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The study was a prospective, longitudinal cohort study. OGTTs were carried out at visit one: 16\u201318 weeks and visit two: 24\u201328\u2009weeks gestation in pregnant women with at least one risk factor for GDM [Body Mass Index &gt;30\u2009kg\/m<jats:sup>2<\/jats:sup>, previous macrosomic baby (&gt;4.5\u2009kg), previous GDM, first degree relative with type 2 diabetes mellitus (T2DM)]. Blood sampling was performed at fasting, 30\u2009min, 1 and 2\u2009hours following a 75-g oral glucose load. Samples were analysed for glucose, total and intact proinsulin, insulin and C-peptide. Hormonal concentrations at visit 1 were compared between those that remained normal glucose tolerant (NGT) and those that progressed to GDM at visit 2 using receiver operator characteristic (ROC) area under the curve (AUC) to assess for discrimination between the two groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Unfortunately, a smaller than planned sample size was recruited due to the start of COVID-19 pandemic midway through the study. 83 pregnant women had OGTT at visit 1. Of these, 12 reached the threshold for GDM at visit 1 and were excluded. In total, data from 66 patients were included for analysis (5 Did Not Attend). Visit 1 hormone comparisons were carried out between 51 who remained NGT and 15 who progressed to GDM at visit 2. There were no significant differences at each time point in ROC AUC between the two groups for total and intact proinsulin and insulin. However, there were significant differences observed in C-peptide ROC AUC at 30 (p=0.041) and 60\u2009min (p=0.003) between the two groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study did not demonstrate significant increase in early proinsulin concentrations in patients that developed GDM. However, there were differences in C-peptide concentrations. The COVID-19 pandemic restricted the recruitment of patient numbers and further studies in a larger cohort will be needed to validate these findings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN16416602\">ISRCTN16416602<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-100039","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T13:15:15Z","timestamp":1757078115000},"page":"e100039","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Pancreatic beta-cell secretory products in the diagnosis and risk stratification of gestational diabetes mellitus: a prospective longitudinal cohort study"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"isrctn16416602","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6022-862X","authenticated-orcid":false,"given":"Gareth","family":"Dunseath","sequence":"first","affiliation":[{"name":"Diabetes Research Group, Swansea University Faculty of Medicine Health and Life Science, Swansea, Wales, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Neath Port Talbot Hospital, Port Talbot, Wales, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0915-9312","authenticated-orcid":false,"given":"Wai-Yee","family":"Cheung","sequence":"additional","affiliation":[{"name":"Diabetes Research Group, Swansea University Faculty of Medicine Health and Life Science, Swansea, Wales, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7206-6530","authenticated-orcid":false,"given":"Stephen","family":"Luzio","sequence":"additional","affiliation":[{"name":"Diabetes Research Group, Swansea University Faculty of Medicine Health and Life Science, Swansea, Wales, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Peter","sequence":"additional","affiliation":[{"name":"Neath Port Talbot Hospital, Port Talbot, Wales, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"2025090506150797000_15.9.e100039.1","unstructured":"International Diabetes Federation 2025 . IDF Diabetes Atlas 11th Edition. 2025."},{"key":"2025090506150797000_15.9.e100039.2","unstructured":"NICE GuidelineNG3 . Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period, 2015. Available: https:\/\/www.nice.org.uk\/guidance\/ng3\/chapter\/1-Recommendations#gestational-diabetes-2"},{"key":"2025090506150797000_15.9.e100039.3","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jogc.2019.12.015","article-title":"Early Gestational Diabetes Mellitus Screening With Glycated Hemoglobin: A Systematic Review","volume":"42","author":"Kattini","year":"2020","journal-title":"J Obstet Gynaecol Can"},{"key":"2025090506150797000_15.9.e100039.4","unstructured":"Guidance for maternal medicine in the evolving coronavirus pandemic (COVID-19) RCOG, 2020."},{"key":"2025090506150797000_15.9.e100039.5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/1471-0528.16482","article-title":"Impact of changes to national UK Guidance on testing for gestational diabetes screening during a pandemic: a single\u2010centre observational study","volume":"128","author":"van\u2010de\u2010l\u2019Isle","year":"2021","journal-title":"BJOG"},{"key":"2025090506150797000_15.9.e100039.6","doi-asserted-by":"crossref","first-page":"100023","DOI":"10.1016\/j.deman.2021.100023","article-title":"Performance of guidelines for the screening and diagnosis of gestational diabetes mellitus during the COVID-19 pandemic: A scoping review of the guidelines and diagnostic studies evaluating the recommended testing strategies","volume":"3","author":"Curtis","year":"2021","journal-title":"Diabet Epidemiol Manag"},{"key":"2025090506150797000_15.9.e100039.7","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2021.030502","article-title":"Early markers of gestational diabetes mellitus: what we know and which way forward?","volume":"31","author":"Omazi\u0107","year":"2021","journal-title":"Biochem Med (Zagreb)"},{"key":"2025090506150797000_15.9.e100039.8","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1447-0756.2012.01870.x","article-title":"Sex-hormone-binding globulin early in pregnancy for the prediction of severe gestational diabetes mellitus and related complications","volume":"38","author":"Caglar","year":"2012","journal-title":"J Obstet Gynaecol Res"},{"key":"2025090506150797000_15.9.e100039.9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ajog.2009.06.065","article-title":"Elevated first-trimester uric acid concentrations are associated with the development of gestational diabetes","volume":"201","author":"Laughon","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"2025090506150797000_15.9.e100039.10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167846","article-title":"Early Antenatal Prediction of Gestational Diabetes in Obese Women: Development of Prediction Tools for Targeted Intervention","volume":"11","author":"White","year":"2016","journal-title":"PLoS One"},{"key":"2025090506150797000_15.9.e100039.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12958-018-0338-x","article-title":"Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot study","volume":"16","author":"K\u00f6ninger","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"2025090506150797000_15.9.e100039.12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00125-017-4505-y","article-title":"Angiopoietin-like protein 8 in early pregnancy improves the prediction of gestational diabetes","volume":"61","author":"Huang","year":"2018","journal-title":"Diabetologia"},{"key":"2025090506150797000_15.9.e100039.13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21062120","article-title":"Extracellular Vesicles in Feto-Maternal Crosstalk and Pregnancy Disorders","volume":"21","author":"Buca","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025090506150797000_15.9.e100039.14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4183\/aeb.2017.278","article-title":"Increased Serum Level of FGF21 in Gestational Diabetes Mellitus","volume":"13","author":"Bonakdaran","year":"2017","journal-title":"Acta Endo (Buc)"},{"key":"2025090506150797000_15.9.e100039.15","unstructured":"Georgiou HM , L\u00f3pez SI , Rice GE . Novel screening approaches for the early detection of gestational diabetes mellitus. Gestational Diabetes 2011;1\u201320."},{"key":"2025090506150797000_15.9.e100039.16","doi-asserted-by":"publisher","DOI":"10.1002\/pd.2733"},{"key":"2025090506150797000_15.9.e100039.17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.tjog.2019.09.015","article-title":"A clinical research study on the respective relationships between visfatin and human fetuin A and pregnancy outcomes in gestational diabetes mellitus","volume":"58","author":"Lu","year":"2019","journal-title":"Taiwan J Obstet Gynecol"},{"key":"2025090506150797000_15.9.e100039.18","first-page":"121","article-title":"Prediction of gestational diabetes mellitus in the first trimester: comparison of maternal fetuin-A, N-terminal proatrial natriuretic peptide, high-sensitivity C-reactive protein, and fasting glucose levels","volume":"63","author":"Kansu-Celik","year":"2019","journal-title":"Arch Endocrinol Metab"},{"key":"2025090506150797000_15.9.e100039.19","doi-asserted-by":"crossref","first-page":"e1033","DOI":"10.1210\/clinem\/dgaa087","article-title":"Plasma Glycated CD59 Predicts Early Gestational Diabetes and Large for Gestational Age Newborns","volume":"105","author":"Ma","year":"2020","journal-title":"J Clin Endocrinol Metabol"},{"key":"2025090506150797000_15.9.e100039.20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/dmrr.390","article-title":"Intermediate metabolism in normal pregnancy and in gestational diabetes","volume":"19","author":"Di Cianni","year":"2003","journal-title":"Diabetes Metabolism Res"},{"key":"2025090506150797000_15.9.e100039.21","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0026-0495(98)90290-6","article-title":"Physiological reduction in fasting plasma glucose concentration in the first trimester of normal pregnancy: the diabetes in early pregnancy study","volume":"47","author":"Mills","year":"1998","journal-title":"Metab Clin Exp"},{"key":"2025090506150797000_15.9.e100039.22","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(91)90012-G"},{"key":"2025090506150797000_15.9.e100039.23","first-page":"E60","article-title":"Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes","volume":"264","author":"Catalano","year":"1993","journal-title":"Am J Physiol"},{"key":"2025090506150797000_15.9.e100039.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(99)70662-9"},{"key":"2025090506150797000_15.9.e100039.25","doi-asserted-by":"publisher","DOI":"10.1007\/BF00296991"},{"key":"2025090506150797000_15.9.e100039.26","doi-asserted-by":"publisher","DOI":"10.2337\/diab.46.4.607"},{"key":"2025090506150797000_15.9.e100039.27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2478\/amb-2014-0002","article-title":"Proinsulin in Healthy Pregnancy, Pregnancy with Gestational Diabetes and after Delivery","volume":"41","author":"Genova","year":"2014","journal-title":"Acta Medica Bulgarica"},{"key":"2025090506150797000_15.9.e100039.28","doi-asserted-by":"publisher","DOI":"10.2337\/diab.44.8.911"},{"key":"2025090506150797000_15.9.e100039.29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2265.1991.tb00296.x","article-title":"Abnormalities in fasting circulating proinsulin concentration in mild gestational diabetes","volume":"34","author":"Dornhorst","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025090506150797000_15.9.e100039.30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022571","article-title":"Proinsulin in the identification and risk stratification of gestational diabetes mellitus: study protocol for a prospective, longitudinal cohort study","volume":"8","author":"Peter","year":"2018","journal-title":"BMJ Open"},{"key":"2025090506150797000_15.9.e100039.31","unstructured":"Centers for disease control and prevention national diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2008."},{"key":"2025090506150797000_15.9.e100039.32","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-017-0943-7","article-title":"Screening and Treatment for Early-Onset Gestational Diabetes Mellitus: a Systematic Review and Meta-analysis","volume":"17","author":"Immanuel","year":"2017","journal-title":"Curr Diab Rep"},{"key":"2025090506150797000_15.9.e100039.33","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.2337\/dc22-1894","article-title":"Insulin Sensitivity and \u03b2-Cell Function During Early and Late Pregnancy in Women With and Without Gestational Diabetes Mellitus","volume":"46","author":"Mittendorfer","year":"2023","journal-title":"Diabetes Care"},{"key":"2025090506150797000_15.9.e100039.34","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.5.867"},{"key":"2025090506150797000_15.9.e100039.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2005.01634.x"},{"key":"2025090506150797000_15.9.e100039.36","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.11.2710"},{"key":"2025090506150797000_15.9.e100039.37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12986-022-00691-3","article-title":"Association between early-pregnancy serum C-peptide and risk of gestational diabetes mellitus: a nested case\u2013control study among Chinese women","volume":"19","author":"Yang","year":"2022","journal-title":"Nutr Metab (Lond)"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-100039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T13:15:20Z","timestamp":1757078120000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-100039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,5]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bmjopen-2025-100039"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-100039","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}